What to know first
Zepbound is harder to source through telehealth than Wegovy because Eli Lilly's distribution agreements with telehealth platforms are narrower than Novo Nordisk's. The programs that prescribe Zepbound either run prior auth on commercial insurance, route patients through LillyDirect's cash-pay channel or both. Programs that prescribe compounded tirzepatide instead of brand Zepbound are excluded here. That is a separate category with separate regulatory exposure.
What we considered
- Will actively prescribe brand Zepbound (not just compounded tirzepatide)
- Runs prior authorization if you have commercial insurance
- Speed from intake to first Zepbound prescription
- Total cash-pay cost when insurance falls through
Some visit links earn us a commission.
Scores out of 10, equal-weighted across five dimensions. How we score
Top pick: Ro Body
PlushCare uses your real commercial insurance and actively runs prior auth on Zepbound. If your plan covers it, you land on a $25-$50 monthly copay. If it doesn't, the cash-pay path is straightforward.
Read the full Ro Body review →
Why Ro Body won this category
PlushCare wins the Zepbound category for the insured patient because getting brand Zepbound on insurance PA is where the real cost optimization happens. Zepbound's LillyDirect cash-pay vials run $299-$449/month depending on dose; the KwikPen version runs $449/month. A successful insurance PA lands patients at $25-$50 monthly copay on most commercial PPO plans. PlushCare processes PAs within 24 hours of intake and is in-network with most major commercial plans.
One Aetna-specific note matters here: CVS Caremark removed Zepbound from Aetna's standard commercial formulary for weight loss as of July 2025. On Aetna, PlushCare will route patients to Wegovy as the preferred agent, or walk through the Zepbound formulary-exception process if tirzepatide is clinically preferred. That routing knowledge is what differentiates a program that files a Zepbound PA on an Aetna plan and gets denied from one that files the correct drug on the first submission.
Who this pick isn't for
PlushCare is not the right pick for cash-pay Zepbound patients who don't want to pay a program membership fee on top of the LillyDirect price. Ro Body's direct Eli Lilly partnership gives access to LillyDirect Zepbound at $299/month (vials) with Ro's $44-$145/month membership, bringing the all-in to $343-$444/month. If you're cash-pay and your insurance won't cover Zepbound, Ro's Lilly partnership is the cleaner path than PlushCare's cash-pay option.
Zepbound is also not available through compounded tirzepatide programs, which is a separate product category with separate regulatory exposure. If you are currently on compounded tirzepatide and want to switch to brand Zepbound, the LillyDirect path through Ro Body or PlushCare is the correct route.
Runner-up: Knownwell
Ro Body is the right runner-up for cash-pay Zepbound patients: the direct Eli Lilly partnership is the cleanest non-insurance access to brand Zepbound vials at $299/month.
Read the full Knownwell review →
Top 3 compared
| Program | Score | Starts from | Lock-in | Time to Rx |
|---|---|---|---|---|
| Ro Body | 7.5 | $373/mo | Month-to-month | 2 days |
| Knownwell | 6.9 | $299/mo | Month-to-month | 14 days |
Other strong picks
Frequently asked questions
Which telehealth programs prescribe brand Zepbound?
How much does Zepbound cost per month through telehealth?
Does insurance cover Zepbound?
Related
